NRG-CC005 (FORTE) Breaking News! Welcome to the FORTE Education and Communication Specialist

June 08 2022

 We are happy to introduce Cheryl Leow (she/her), who recently joined the NRG Oncology Pittsburgh Operations Center team as the NRG-CC005/FORTE Education and Communication Specialist. She has long-standing interest in partnering with study teams across multiple fields to improve the conduct of research activities, from increasing participant enrollment to engaging with clinical sites and community partners. Prior to joining the FORTE team, Cheryl served as the primary research coordinator for a PCORI-funded, behavioral health clinical trial for Sickle Cell disease. In this role, she managed participant recruitment and retention, coordinating clinic and virtual enrollment across several sites. With the FORTE study, Cheryl is excited to explore innovative methods of bringing awareness of clinical research to both providers and the wider public.

Cheryl has earned degrees from the University of Virginia (Go ‘Hoos!). She is an avid knitter and loves spending time with her spouse and two cats (Zabrina and Zelda). “I am excited to collaborate with the FORTE team and the entire NRG site network to bring this trial to patients and providers alike. If you are attending the NRG Semiannual meeting in Chicago, stop by a FORTE session and introduce yourself!”

Cheryl can be reached with questions and suggestions about study promotion at:

FORTE Accrual Updates and Milestones (as of May 31, 2022)

First accrual: February 2022!

Top accruing sites:

  • UPMC-Presbyterian Hospital – 26 accrued
  • Park Nicollet Clinic - Saint Louis Park – 19 accrued

Most recent randomizations:

  • Kaiser Permanente-Vallejo – May 25, 2022
  • Park Nicollet Clinic - Saint Louis Park – May 25, 2022
  • UPMC-Presbyterian Hospital – May 25, 2022

We commend all sites on your efforts to accrue patients! Continue the strong recruitment efforts!

Remember to follow FORTE on social media!

1-1.png   LinkedIn: @FORTE Study  

2.gif   Twitter: @fortestudy

3.png  Facebook: @FORTE Study

4.png  Instagram:@fortestudy

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:
(1-800) 477-7227

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.